The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, H.
Right arrow Articles by Gaynor, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, H.
Right arrow Articles by Gaynor, R. B.
The Journal of Immunology, 2002, 168: 3721-3731.
Copyright © 2002 by The American Association of Immunologists

I-{kappa}B Kinases {alpha} and {beta} Have Distinct Roles in Regulating Murine T Cell Function1

Hong Ren*, Aurelia Schmalstieg*, Nicolai S. C. van Oers{dagger} and Richard B. Gaynor2,*

* Division of Hematology-Oncology, Department of Medicine, Harold Simmons Cancer Center, and {dagger} Center for Immunology and Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390

NF-{kappa}B is a transcription factor that regulates a variety of genes involved in the control of the immune and inflammatory responses. Activation of NF-{kappa}B is mediated by an inducible I-{kappa}B kinase (IKK) complex comprised of two catalytic subunits, IKK{alpha} and IKK{beta}. In this study, the role of these kinases in the development and function of T lymphocytes was explored using transgenic mice expressing the dominant-negative forms of one or both kinases under the control of a T cell-specific promoter. Activation of the NF-{kappa}B pathway in thymocytes isolated from these transgenic mice following treatment with either PMA and ionomycin or anti-CD3 was markedly inhibited. Although inhibition of IKK{alpha} and/or IKK{beta} function did not alter T cell development in these transgenic mice, the proliferative response to anti-CD3 was reduced in thymocytes isolated from mice expressing dominant-negative IKK{beta}. However, inhibition of both IKK{alpha} and IKK{beta} was required to markedly reduce cytokine production in thymocytes isolated from these transgenic mice. Finally, we demonstrated that IKK{alpha} and IKK{beta} have opposite roles on the regulation of anti-CD3-induced apoptosis of double-positive thymocytes. These results suggest that IKK{alpha} and IKK{beta} have distinct roles in regulating thymocyte function.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. J. Jost, S. Weiss, U. Ferch, O. Gross, T. W. Mak, C. Peschel, and J. Ruland
Bcl10/Malt1 Signaling Is Essential for TCR-Induced NF-{kappa}B Activation in Thymocytes but Dispensable for Positive or Negative Selection
J. Immunol., January 15, 2007; 178(2): 953 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Tu, S. Prajapati, K.-J. Park, N. J. Kelly, Y. Yamamoto, and R. B. Gaynor
IKK{alpha} Regulates Estrogen-induced Cell Cycle Progression by Modulating E2F1 Expression
J. Biol. Chem., March 10, 2006; 281(10): 6699 - 6706.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. B. DeMeritt, L. E. Milford, and A. D. Yurochko
Activation of the NF-{kappa}B Pathway in Human Cytomegalovirus-Infected Cells Is Necessary for Efficient Transactivation of the Major Immediate-Early Promoter
J. Virol., May 1, 2004; 78(9): 4498 - 4507.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
S. C. Bunnell
Determining the Destiny of NF-{kappa} B after TCR Ligation: It's CARMA1
Mol. Interv., October 1, 2002; 2(6): 356 - 360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.